• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Zacks Upgrade Highlights a Shifting Edge AI Earnings Narrative for Ambarella (AMBA)

    Simply Wall St·07/21/2026 22:23:23
    Listen to the news
    • Zacks recently upgraded Ambarella to a Rank #2 (Buy), reflecting an improved earnings outlook supported by upward revisions to analyst profit forecasts.
    • This shift in expectations highlights how Ambarella’s evolving edge AI and IoT positioning is feeding directly into more optimistic earnings models.
    • We’ll now examine how this upgraded earnings outlook could reshape Ambarella’s investment narrative around edge AI growth and risk.

    AI is about to change healthcare. These 39 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

    Ambarella Investment Narrative Recap

    To own Ambarella, you need to believe that its edge AI and IoT chips can turn growing design wins into durable, higher margin revenue, despite current losses and dependence on volatile consumer and IoT demand. The Zacks Rank #2 upgrade signals improving earnings estimates, which may support the near term catalyst of confidence in Ambarella’s AI ramp, but it does not remove the key risk that heavy IoT exposure and rising R&D spend could still pressure margins if demand softens.

    The recent long term co development agreement with Hanwha, with potential revenue of more than US$800,000,000 over more than 10 years, is particularly relevant here. It reinforces the idea that Ambarella’s edge AI platforms are gaining traction in security, robotics, and industrial markets, which could help balance its IoT concentration. How much this contract and the upgraded earnings outlook ultimately influence revenue visibility and margin trends will be central to the next phase of the Ambarella story.

    Yet beneath the improved earnings outlook, investors should be aware of how Ambarella’s reliance on volatile IoT demand and concentrated Asian fulfillment partners could...

    Read the full narrative on Ambarella (it's free!)

    Ambarella's narrative projects $526.3 million revenue and $74.3 million earnings by 2028. This requires 14.8% yearly revenue growth and a $162.9 million earnings increase from $-88.6 million today.

    Uncover how Ambarella's forecasts yield a $97.45 fair value, a 37% upside to its current price.

    Exploring Other Perspectives

    AMBA 1-Year Stock Price Chart
    AMBA 1-Year Stock Price Chart

    Some of the lowest ranked analysts paint a far more cautious picture, assuming about 13.7 percent annual revenue growth and continued losses, so you should weigh this pessimism against the recent Zacks upgrade and decide which edge AI risk profile you are most comfortable with.

    Explore 5 other fair value estimates on Ambarella - why the stock might be worth just $80.00!

    The Verdict Is Yours

    Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

    Seeking Other Investments?

    Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:

    • Invest in the nuclear renaissance through our list of 90 elite nuclear energy infrastructure plays powering the global AI revolution.
    • Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 29 best rare earth metal stocks of the very few that mine this essential strategic resource.
    • The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 16 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.